Eli Lilly

Senators probe whether Pfizer, Lilly DTC platforms create 'potential for inappropriate prescribing'
Fierce Pharma
Tue, 10/22/24 - 11:32 pm
Senate
Pfizer
Eli Lilly
telehealth
DTC
FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage
Pharma Voice
Mon, 10/21/24 - 09:37 am
FDA
GLP-1 agonists
Ozempic
Wegovy
Novo Nordisk
drug shortages
Eli Lilly
Zepbound
On road to crowded Crohn's disease market, Lilly's Omvoh bests J&J's Stelara in head-to-head study
Fierce Pharma
Tue, 10/15/24 - 10:15 am
Eli Lilly
Crohn's Disease
Omvoh
clinical trials
JNJ
Stelara
FDA, facing pressure, to review position on Zepbound, Mounjaro shortage
BioPharma Dive
Mon, 10/14/24 - 11:17 pm
Eli Lilly
drug shortages
Zebound
Mounjaro
FDA
Lilly picks UK for first European Gateway Lab as part of $364M investment plan
Fierce Biotech
Mon, 10/14/24 - 10:28 am
Eli Lilly
Gateway Labs
incubators
Europe
FDA to reconsider decision barring compounded versions of Lilly weight loss drug
Reuters
Sun, 10/13/24 - 11:33 am
FDA
Eli Lilly
compounded drugs
drug shortages
obesity drugs
tirzepatide
Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.
BioPharma Dive
Fri, 10/11/24 - 11:10 am
Novo Nordisk
Eli Lilly
obesity
Zebound
Wegovy
CagriSema
Amgen
MariTide
oforglipron
Veru
enobosarm
nimacimab
Skye Bioscience
Lilly names Mount Sinai scientist as first chief AI officer
BioPharma Dive
Wed, 10/9/24 - 09:05 pm
Eli Lilly
artificial intelligence
Lilly, Insitro Ink Unique AI Deal, Eye Novel Treatments for Metabolic Diseases
BioSpace
Wed, 10/9/24 - 09:46 am
Insitro
Eli Lilly
siRNA
MASH
Weight loss gold rush: Developers vie for next blockbuster treatment
Pharmaphorum
Tue, 10/8/24 - 09:45 am
R&D
obesity
weight loss
Novo Nordisk
Eli Lilly
Roche
Boehringer Ingelheim
Lilly's weight-loss drug removed from FDA's shortage list
Reuters
Thu, 10/3/24 - 10:06 am
Eli Lilly
FDA
drug shortages
Mounjaro
High-flying Eli Lilly pushes more chips forward with $4.5B 'Medicine Foundry' project
Fierce Pharma
Wed, 10/2/24 - 11:27 am
Eli Lilly
JNJ
medicine foundry
drug manufacturing
Weight Loss From GLP-1 Drugs Not As Robust In Real-World Settings
Forbes
Wed, 10/2/24 - 11:20 am
weight loss
obesity
GLP-1 agonist
Ozempic
Wegovy
Novo Nordisk
Zepbound
Mounjaro
Eli Lilly
Patients sue over alleged stomach paralysis linked to Ozempic, Mounjaro
Beckers Hospital Review
Tue, 10/1/24 - 10:45 am
legal
Novo Nordisk
Eli Lilly
Ozempic
Mounjaro
gastroparesis
Radiopharma biotech Aktis sees Big Pharma backers return for $175M series B
Fierce Biotech
Mon, 09/30/24 - 09:40 am
Eli Lilly
Aktis Oncology
funding
radiopharmaceuticals
Inside the GLP-1 'price war'
Beckers Hospital Review
Tue, 09/24/24 - 11:52 am
GLP-1 agonists
obesity
weight loss
Eli Lilly
Novo Nordisk
Ozempic
Wegovy
Zepbound
Mounjaro
drug pricing
Eli Lilly's Alzheimer's drug approved in Japan
Reuters
Tue, 09/24/24 - 11:39 am
Eli Lilly
Japan
donanemab
Alzheimer's disease
New migraine drugs less effective than previous generation of triptan meds: BMJ study
Fierce Pharma
Thu, 09/19/24 - 09:29 pm
migraines
BMJ
Pfizer
Nurtec
AbbVie
Ubrelvy
Eli Lilly
Reyvow
Novartis heaps pressure on Lilly with broad FDA approval for Kisqali in early breast cancer
Fierce Pharma
Tue, 09/17/24 - 11:08 pm
Novartis
FDA
Eli Lilly
breast cancer
Kisqali
ESMO 2024: Eli Lilly brings the competition to Novartis with new results in mCRPC
Clinical Trials Arena
Tue, 09/17/24 - 11:13 am
Eli Lilly
ESMO
lutetium zadavotide guraxetan
Astellas
Janssen
metastatic castration-resistant prostate cancer

Pages